US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist
  • 29.150
  • -0.550-1.85%
Close Dec 23 16:00 ET
  • 29.150
  • 0.0000.00%
Post 16:01 ET
940.09MMarket Cap12.46P/E (TTM)

Collegium Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
16.53%159.3M
7.18%145.28M
0.11%144.92M
22.17%566.77M
15.53%149.75M
7.63%136.71M
9.71%135.55M
72.85%144.77M
67.56%463.93M
373.72%129.62M
Operating revenue
16.53%159.3M
7.18%145.28M
0.11%144.92M
22.17%566.77M
15.53%149.75M
7.63%136.71M
9.71%135.55M
72.85%144.77M
67.56%463.93M
373.72%129.62M
Cost of revenue
10.83%62.51M
-11.75%54.47M
-20.63%53.47M
-5.44%240.6M
-30.96%55.12M
-17.27%56.4M
-13.30%61.72M
91.08%67.37M
101.54%254.45M
178.21%79.83M
Gross profit
20.52%96.79M
23.00%90.81M
18.16%91.46M
55.70%326.17M
90.06%94.63M
36.49%80.31M
40.99%73.83M
59.60%77.4M
39.09%209.49M
3,835.11%49.79M
Operating expense
75.52%61.96M
13.46%43.34M
-20.45%41.98M
-9.63%159.21M
-13.38%32.94M
-8.01%35.3M
-7.42%38.19M
-9.80%52.78M
37.19%176.17M
34.81%38.03M
Selling and administrative expenses
75.52%61.96M
13.46%43.34M
-20.45%41.98M
-7.54%159.21M
-13.38%32.94M
-8.01%35.3M
-7.42%38.19M
-3.21%52.78M
44.74%172.19M
42.97%38.03M
Research and development costs
----
----
----
--0
----
----
----
----
-57.86%3.98M
--0
Operating profit
-22.60%34.84M
33.22%47.47M
100.89%49.47M
401.10%166.96M
424.69%61.69M
119.93%45.01M
220.73%35.63M
345.90%24.63M
50.05%33.32M
139.79%11.76M
Net non-operating interest income expense
6.88%-15.11M
37.26%-11.19M
31.20%-12.85M
-8.94%-67.72M
23.38%-14.98M
14.74%-16.23M
-0.45%-17.84M
-220.58%-18.68M
-196.00%-62.17M
-311.19%-19.55M
Non-operating interest income
-27.72%3.28M
9.19%4.4M
63.34%4.49M
1,391.40%15.62M
318.99%4.3M
41,154.55%4.54M
80,440.00%4.03M
68,575.00%2.75M
8,625.00%1.05M
34,133.33%1.03M
Non-operating interest expense
-11.43%18.39M
-28.71%15.59M
-19.08%17.34M
31.84%83.34M
-6.29%19.28M
9.04%20.77M
23.10%21.86M
267.47%21.43M
200.81%63.21M
332.52%20.58M
Other net income (expense)
-4.15M
-7.18M
-23.5M
0
-23.5M
Special income (charges)
---4.15M
---7.18M
--0
---23.5M
--0
--0
--0
---23.5M
--0
--0
-Less：Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
--0
----
-Less:Other special charges
--4.15M
--7.18M
----
--23.5M
--0
----
----
--23.5M
----
----
Income before tax
-45.87%15.58M
63.49%29.1M
308.59%36.62M
362.53%75.73M
699.54%46.71M
1,909.99%28.78M
367.79%17.8M
-10.83%-17.56M
-754.98%-28.85M
79.96%-7.79M
Income tax
-23.36%6.25M
98.14%9.49M
6,900.76%8.91M
817.24%27.58M
2,594.93%14.77M
735.79%8.15M
429.21%4.79M
95.28%-131K
94.87%-3.85M
95.72%-592K
Net income
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
4,415.10%20.63M
350.57%13.01M
-33.34%-17.43M
-134.96%-25M
71.24%-7.2M
Net income continuous Operations
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
4,415.10%20.63M
350.57%13.01M
-33.34%-17.43M
-134.96%-25M
71.24%-7.2M
Minority interest income
Net income attributable to the parent company
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
4,415.10%20.63M
350.57%13.01M
-33.34%-17.43M
-134.96%-25M
71.24%-7.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
4,415.10%20.63M
350.57%13.01M
-33.34%-17.43M
-134.96%-25M
71.24%-7.2M
Basic earnings per share
-52.46%0.29
57.89%0.6
268.63%0.86
293.24%1.43
557.14%0.96
6,000.00%0.61
353.33%0.38
-30.77%-0.51
-136.10%-0.74
71.23%-0.21
Diluted earnings per share
-49.06%0.27
52.94%0.52
239.22%0.71
274.32%1.29
495.24%0.83
5,200.00%0.53
326.67%0.34
-30.77%-0.51
-139.78%-0.74
71.23%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 16.53%159.3M7.18%145.28M0.11%144.92M22.17%566.77M15.53%149.75M7.63%136.71M9.71%135.55M72.85%144.77M67.56%463.93M373.72%129.62M
Operating revenue 16.53%159.3M7.18%145.28M0.11%144.92M22.17%566.77M15.53%149.75M7.63%136.71M9.71%135.55M72.85%144.77M67.56%463.93M373.72%129.62M
Cost of revenue 10.83%62.51M-11.75%54.47M-20.63%53.47M-5.44%240.6M-30.96%55.12M-17.27%56.4M-13.30%61.72M91.08%67.37M101.54%254.45M178.21%79.83M
Gross profit 20.52%96.79M23.00%90.81M18.16%91.46M55.70%326.17M90.06%94.63M36.49%80.31M40.99%73.83M59.60%77.4M39.09%209.49M3,835.11%49.79M
Operating expense 75.52%61.96M13.46%43.34M-20.45%41.98M-9.63%159.21M-13.38%32.94M-8.01%35.3M-7.42%38.19M-9.80%52.78M37.19%176.17M34.81%38.03M
Selling and administrative expenses 75.52%61.96M13.46%43.34M-20.45%41.98M-7.54%159.21M-13.38%32.94M-8.01%35.3M-7.42%38.19M-3.21%52.78M44.74%172.19M42.97%38.03M
Research and development costs --------------0-----------------57.86%3.98M--0
Operating profit -22.60%34.84M33.22%47.47M100.89%49.47M401.10%166.96M424.69%61.69M119.93%45.01M220.73%35.63M345.90%24.63M50.05%33.32M139.79%11.76M
Net non-operating interest income expense 6.88%-15.11M37.26%-11.19M31.20%-12.85M-8.94%-67.72M23.38%-14.98M14.74%-16.23M-0.45%-17.84M-220.58%-18.68M-196.00%-62.17M-311.19%-19.55M
Non-operating interest income -27.72%3.28M9.19%4.4M63.34%4.49M1,391.40%15.62M318.99%4.3M41,154.55%4.54M80,440.00%4.03M68,575.00%2.75M8,625.00%1.05M34,133.33%1.03M
Non-operating interest expense -11.43%18.39M-28.71%15.59M-19.08%17.34M31.84%83.34M-6.29%19.28M9.04%20.77M23.10%21.86M267.47%21.43M200.81%63.21M332.52%20.58M
Other net income (expense) -4.15M-7.18M-23.5M0-23.5M
Special income (charges) ---4.15M---7.18M--0---23.5M--0--0--0---23.5M--0--0
-Less：Restructuring and merger&acquisition --------------0------------------0----
-Less:Other special charges --4.15M--7.18M------23.5M--0----------23.5M--------
Income before tax -45.87%15.58M63.49%29.1M308.59%36.62M362.53%75.73M699.54%46.71M1,909.99%28.78M367.79%17.8M-10.83%-17.56M-754.98%-28.85M79.96%-7.79M
Income tax -23.36%6.25M98.14%9.49M6,900.76%8.91M817.24%27.58M2,594.93%14.77M735.79%8.15M429.21%4.79M95.28%-131K94.87%-3.85M95.72%-592K
Net income -54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M4,415.10%20.63M350.57%13.01M-33.34%-17.43M-134.96%-25M71.24%-7.2M
Net income continuous Operations -54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M4,415.10%20.63M350.57%13.01M-33.34%-17.43M-134.96%-25M71.24%-7.2M
Minority interest income
Net income attributable to the parent company -54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M4,415.10%20.63M350.57%13.01M-33.34%-17.43M-134.96%-25M71.24%-7.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M4,415.10%20.63M350.57%13.01M-33.34%-17.43M-134.96%-25M71.24%-7.2M
Basic earnings per share -52.46%0.2957.89%0.6268.63%0.86293.24%1.43557.14%0.966,000.00%0.61353.33%0.38-30.77%-0.51-136.10%-0.7471.23%-0.21
Diluted earnings per share -49.06%0.2752.94%0.52239.22%0.71274.32%1.29495.24%0.835,200.00%0.53326.67%0.34-30.77%-0.51-139.78%-0.7471.23%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+2.49%
Tesla
TSLA
+2.27%
Alphabet-A
GOOGL
+1.68%
Alphabet-C
GOOG
+1.57%
Taylor Morrison Home
TMHC
+1.41%

Unlock the Full List